Actively Recruiting
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Led by China National Center for Cardiovascular Diseases · Updated on 2019-10-09
200000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating clinical performance and quality measures for adults with acute ST-elevation myocardial infarction (STEMI) in China. This study aims to develop quality improvement strategies and tools to enhance treatment and clinical outcomes for patients with STEMI. It is conducted as an annual survey enrolling all eligible inpatients to assess hospital performance and care variations across regions. The study involves all participating hospitals implementing quality improvement strategies, including summaries of clinical performance, clinical pathways, and professional training programs. Eligible patients are consecutively recruited using consistent methods, and the study tracks reperfusion rates and other performance measures yearly to compare improvements over time. Participants will have their demographic data, clinical features, diagnostic tests, medications, procedures, and in-hospital outcomes collected. Researchers measure various outcomes such as medication use at arrival and discharge, timing of treatments like thrombolysis and primary PCI, mortality rates, readmission rates, and cost during hospitalization. The study continues long term with annual data collection to monitor quality and outcomes up to the year 2035.
CONDITIONS
Brief Title
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with STEMI who arrive at the hospital within 48 hours from the symptoms onset
- Adults aged 18 years or older
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 10 days (during hospitalization)
Participants who undergo routine care for acute ST-elevation myocardial infarction are observed, and relevant clinical information is collected during hospitalization.
Daily assessments during hospitalization
Duration - 30 days from admission
Participants are followed for up to 30 days after hospital discharge to monitor outcomes such as mortality and readmission rates.
Follow-up visits or contacts up to 30 days
Trial Site Locations
Total: 1 location
1
Hongjian Wang
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
H
Hongjian Wang
K
Kefei Dou
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here